Anatomic Pathology Market Expected to Reach US ~$65.54 Billion and CAGR 7.3% by 2030 – Polaris Market Research
The global anatomic pathology market size is expected to reach USD 65.54 billion by 2030, according to a new study by Polaris Market Research.
The global industry is expected to increase rapidly due to the growing focus on customized care and a large number of supporting programs and training modules provided by the government. The geriatric population is rapidly growing, as is the incidence rate of cancer and other chronic disorders. The industry is being driven by an increase in chronic disease cases and a need to address the quick diagnosis of medical disorders. Modern anatomic pathology technology is becoming more widely used because of the significant rise in cancer cases.
Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/anatomic-pathology-market/request-for-sample
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)
The industry is being driven by an increase in chronic disease cases and a need to address the quick diagnosis of medical disorders. Because the elderly are more susceptible to numerous illnesses, this demographic trend is expected to significantly increase the prevalence of several chronic diseases, including cancer, worldwide.
Furthermore, rising awareness and increased patient pool in developing countries propel the industry forward. Additionally, the industry is being driven by an increase in healthcare expenditure and the use of biomarkers during illness diagnosis.
Over the projected period, the drug discovery and development segment is expected to increase at a profitable rate. During preclinical studies, pathologists’ tissue analysis provides pharmaceutical companies with a wide range of information. Moreover, the biologic’s manufacturing service is also expected to register significant growth in the overall industry. This is due to the robust pipeline of new biological drugs due to the growing commercial success of biopharma companies across developed and developing economies paving the segment’s growth.
Agilent Technologies, Abcam plc, Amos Scientific Pty Ltd., Bio SB, BioGenex, Bright Instruments, Cell Signaling Technology, Inc., Beckton, CellPath Ltd., Danaher Corporation, Diapath S.p.A, Dickson and Company, Cardinal Health, F. Hoffmann-La Roche AG, Hologic, Inc., Jinhua Yidi Medical Equipment Co., Ltd., Histo-Line Laboratories, Laboratory Corporation of America Holdings, Lupetec, Medimeas, Merck KGaA, MICROS AUSTRIA, Milestone Medical, NeoGenomics Laboratories, Inc., MEDITE Medical GmbH, Quest Diagnostics Incorporated, R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED, PHC Holdings Corporation, Sakura Finetek, and SLEE medical GmbH are some of the major players in the market.
In December 2021, Quest Diagnostics Incorporated introduced the liquid biopsy-based Target Selector NGS Lung Panel test. In October 2021, Roche partnered with PathAI, a global leader in artificial intelligence (AI)-based technologies. The firms will collaborate on pathologists’ embedded image analysis workflow as part of the development and distribution arrangement.
Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/anatomic-pathology-market/inquire-before-buying
(You may enquire about a reported quote OR available discount offers to our sales team before purchase.)
Polaris Market Research has segmented the anatomic pathology market report based on product, application, end-use, and region:
Anatomic Pathology, Product Outlook (Revenue – USD Billion, 2018 – 2030)
- Microtomes & Cryostat
- Tissue Processors
- Automatic Stainers
- Whole Slide Imaging (WSI) Scanners
- Other Products
- Reagents & Antibodies
- Probes & Kits
Anatomic Pathology, Application Outlook (Revenue – USD Billion, 2018 – 2030)
- Disease Diagnosis
- Drug Discovery and Development
Anatomic Pathology, End-Use Outlook (Revenue – USD Billion, 2018 – 2030)
- Research Laboratories
- Diagnostic Laboratories
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.
Polaris Market Research